BMT CTN Protocol 1204

Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies.

Below are protocol-related documents, which may be periodically updated.

             Protocol Co-Chair: Carl Allen, MD (832-824-4312) ceallen@txch.org

             Protocol Co-Chair: M. Pulsipher, MD mpulsipher@chla.usc.edu

             Protocol Officer: Mary Eapen, MD (414-805-0700) meapen@mcw.edu

             Protocol Coordinator: Alyssa Ramirez (301-251-1161) aramirez@emmes.com           

             Medical Monitor: Liza Thiel, MD ethiel@mcw.edu

                   

Accrual for the BMT CTN 1204 trial closed on December 4, 2015.